These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 32456404)

  • 21. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
    Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
    BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis.
    Rotshild V; Hirsh-Raccah B; Miskin I; Muszkat M; Matok I
    Sci Rep; 2021 Nov; 11(1):22777. PubMed ID: 34815503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).
    Tan RQ; Li WTV; Shum WZ; Chu SC; Li HL; Shea YF; Chung TW
    Syst Rev; 2021 Mar; 10(1):73. PubMed ID: 33691796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval.
    Tumban E
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33396343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials.
    Medeiros KS; Costa APF; Sarmento ACA; Freitas CL; Gonçalves AK
    BMJ Open; 2022 Feb; 12(2):e050278. PubMed ID: 35210336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.
    Chen M; Yuan Y; Zhou Y; Deng Z; Zhao J; Feng F; Zou H; Sun C
    Infect Dis Poverty; 2021 Jul; 10(1):94. PubMed ID: 34225791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
    Speich B; Chammartin F; Smith D; Stoeckle MP; Amico P; Eichenberger AL; Hasse B; Schuurmans MM; Müller T; Tamm M; Dickenmann M; Abela IA; Trkola A; Hirsch HH; Manuel O; Cavassini M; Hemkens LG; Briel M; Mueller NJ; Rauch A; Günthard HF; Koller MT; Bucher HC; Kusejko K;
    Trials; 2021 Oct; 22(1):724. PubMed ID: 34674742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sufficient Sleep, Time of Vaccination, and Vaccine Efficacy: A Systematic Review of the Current Evidence and a Proposal for COVID-19 Vaccination.
    Rayatdoost E; Rahmanian M; Sanie MS; Rahmanian J; Matin S; Kalani N; Kenarkoohi A; Falahi S; Abdoli A
    Yale J Biol Med; 2022 Jun; 95(2):221-235. PubMed ID: 35782481
    [No Abstract]   [Full Text] [Related]  

  • 32. The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19.
    Wang J; Zhang Q; Wang H; Gong W
    Front Biosci (Landmark Ed); 2022 May; 27(5):157. PubMed ID: 35638424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
    Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND
    Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review.
    Sandoval C; Guerrero D; Muñoz J; Godoy K; Souza-Mello V; Farías J
    Expert Rev Vaccines; 2023; 22(1):35-53. PubMed ID: 36484136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2.
    Lee KM; Lin SJ; Wu CJ; Kuo RL
    Biomed J; 2023 Feb; 46(1):70-80. PubMed ID: 36642222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future.
    Calvo Fernández E; Zhu LY
    Br J Clin Pharmacol; 2021 Sep; 87(9):3408-3424. PubMed ID: 33289156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mRNA Vaccines in the COVID-19 Pandemic and Beyond.
    Hogan MJ; Pardi N
    Annu Rev Med; 2022 Jan; 73():17-39. PubMed ID: 34669432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review.
    Asghar N; Mumtaz H; Syed AA; Eqbal F; Maharjan R; Bamboria A; Shrehta M
    Immunol Med; 2022 Dec; 45(4):225-237. PubMed ID: 35491898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.